selected scholarly activity
-
chapters
-
conferences
- Epidemiology, Diagnosis and Management of Neonatal Thrombosis. Blood. 3656-3656. 2019
- An assessment of the use of palivizumab over 12 years from a Canadian Registry (CARESS). European Respiratory Journal. 2019
- Respiratory Illness (RI) and Respiratory Syncytial Virus (RSV)-Related Hospitalization (RSVH) in Infants with Congenital Diaphragmatic Hernia (CDH) in the Caress Registry (2005-2017). Value in Health. S150-S150. 2018
- RESPIRATORY ILLNESS AND RESPIRATORY SYNCYTIAL VIRUS (RSV)-RELATED HOSPITALIZATION (RSVH) IN INFANTS WITH CONGENITAL AIRWAY ANOMALIES (CAA) IN THE CARESS REGISTRY (2005-2016). Value in Health. A86-A86. 2017
- Palivizumab Use In Canada In The Caress Database 2005-2015. American Journal of Respiratory and Critical Care Medicine. 2017
- Respiratory Illness And Respiratory Syncytial Virus (rsv)-Related Hospitalizations (rsvh) In Infants With Congenital Airway Anomalies (caa) In The Caress Registry (2005-2015). American Journal of Respiratory and Critical Care Medicine. 2017
- COMPARING PALIVIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMODYNAMICALLY SIGNIFICANT CONGENITAL HEART DISEASE (HSCHD) IN THE CARESS DATABASE (2005-2015) IN THE FIRST VERSUS SECOND YEAR OF LIFE. European Journal of Pediatrics. 1494-1494. 2016
- COMPARISON OF FIRST-AND SECOND-YEAR PALIVIZUMAB PROPHYLAXIS IN PATIENTS WITH CHRONIC LUNG DISEASE (CLD) IN THE CARESS DATABASE (2005-2015). European Journal of Pediatrics. 1512-1512. 2016
- CREATING A UNIVERSAL RISK FACTOR MODEL FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) HOSPITALISATIONS IN 33-35 WEEKS' GESTATIONAL AGE (WGA) INFANTS IN THE NORTHERN HEMISPHERE. European Journal of Pediatrics. 1553-1553. 2016
- NEONATAL PORTAL VEIN THROMBOSIS: A SINGLE INSTITUTIONAL EXPERIENCE OF SHORT AND LONG-TERM OUTCOMES. European Journal of Pediatrics. 1765-1766. 2016
- THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS HOSPITALISATION (RSVH) IN 33-35 WEEK GESTATIONAL AGE (wGA) INFANTS DURING THE VIRAL SEASON IN THE NORTHERN HEMISPHERE. European Journal of Pediatrics. 1553-1554. 2016
- Comparison Of First- And Second-Season Palivizumab Prophylaxis In Patients With Congenital Airway Anomalies (Caa) In The Caress Database (2005-2015). Value in Health. A111-A112. 2016
- Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations. European Respiratory Journal. 2015
- Respiratory related hospitalizations in premature infants prophylaxed with palivizumab In the Canadian registry of palivizumab (CARESS). European Respiratory Journal. 2015
- Working with families: Lessons from a Canadian registry of palivizumab use. European Respiratory Journal. 2015
- Do preterm infants with patent ductus arteriosus (PDA) who fail indomethacin treatment have lower platelet counts?: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 422-423. 2015
- Comparing First- and Second-Season Palivizumab Prophylaxis In Patients with Hemodynamically Significant Congenital Heart Disease in the Caress Database (2005-2014). Value in Health. A232-A233. 2015
- Respiratory Related Hospitalizations In Premature Infants Prophylaxed With Palivizumab In the Canadian Registry of Palivizumab (Caress). Value in Health. A231-A231. 2015
- Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus Infection. Value in Health. A228-A229. 2015
- Respiratory syncytial virus (RSV) hospitalization in infants with congenital airway anomalies (CAA) in the canadian registry of palivizumab (CARESS) after prophylaxis (2005-2012). European Respiratory Journal. 2014
- Respiratory Syncytial Virus Prophylaxis In Down Syndrome: A Prospective Cohort Study. Value in Health. A171-A171. 2014
- Factors Associated with Compliance with Palivizumab Prophylaxis in the Canadian RSV Evaluation Study for Synagis (CARESS) Registry (2005-2012). Value in Health. A368-A368. 2013
- RESPIRATORY SYNCYTIAL VIRUS HOSPITALIZATION IN INFANTS WITH CONGENITAL AIRWAY ANOMALIES IN THE CANADIAN REGISTRY OF SYNAGIS (R) (CARESS) FOLLOWING PROPHYLAXIS (2005-2012). Value in Health. A366-A367. 2013
- RESPIRATORY SYNCYTIAL VIRUS HOSPITALIZATIONS IN THE CANADIAN REGISTRY FOR SYNAGIS (CARESS). Value in Health. A366-A366. 2013
- RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012). European Respiratory Journal. 2013
- RSV hospitalization in infants with neuromuscular disease in the Canadian registry of palivizumab after prophylaxis (2005-2012). European Respiratory Journal. 2013
- Subcutaneous injection of enoxaparin in neonates. Journal of Thrombosis and Haemostasis. 1202-1202. 2013
- Rsv Hospitalization In Infants With Neuromuscular Disease In The Canadian Registry Of Synagis® (Caress) Following Prophylaxis (2005-2012). Value in Health. A243-A243. 2013
- Factors associated with compliance with palivizumab treatment in the Canadian rSV evaluation study for synagis (CARESS) registry (32005-2011). European Respiratory Journal. 2012
- RSV hospitalization in Down syndrome in the Canadian Registry of Synagis (CARESS) following prophylaxis (2006-2011). European Respiratory Journal. 2012
- Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011). European Respiratory Journal. 2012
- A COMPARATIVE STUDY OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PROPHYLAXIS IN PREMATURE INFANTS. Value in Health. A398-A398. 2011
- CARESS: THE CANADIAN REGISTRY OF SYNAGIS (2005-2010). Value in Health. A398-A398. 2011
- RESPIRATORY SYNCYTIAL VIRUS (RSV) PROPHYLAXIS IN SPECIAL POPULATIONS. Value in Health. A398-A399. 2011
- RESPIRATORY SYNCYTIAL VIRUS HOSPITALIZATIONS IN THE CANADIAN REGISTRY FOR SYNAGIS (CARESS). Value in Health. A398-A398. 2011
- 1200 Caress: The Canadian Registry of Synagis (2006-2009). Pediatric Research. 593-593. 2010
- 1201 Respiratory Syncytial Virus Prophylaxis in Special Populations. Pediatric Research. 594-594. 2010
- CARESS: THE CANADIAN REGISTRY OF SYNAGIS (2006-2009). Value in Health. A318-A318. 2010
- RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS IN SPECIAL POPULATIONS. Value in Health. A318-A318. 2010
- Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada. Current Medical Research and Opinion. 2191-2196. 2009
- PIH56 CARESS: THE CANADIAN REGISTRY OF SYNAGIS, SUMMARY OF 2006–2008 RSV SEASONS. Value in Health. A172-A172. 2009
- PIH11 IMPACT OF THE RISK SCORING MODEL ON THE COST-EFFECTIVENESS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIALVIRUS PROPHYLAXIS IN PREMATURE INFANTS WITH A GESTATIONAL AGE OF 32-35 WEEKS IN CANADA. Value in Health. A248-A249. 2008
- PIH22 CARESS: THE CANADIAN REGISTRY OF SYNAGIS(®). Value in Health. A252-A252. 2008
- Nutrient intake, feeding practices and growth patterns in breast- and formula-fed preterm infants in the first year of life. Pediatric Research. 286A-286A. 2002
- Iron, zinc and copper status of preterm infants: Effects of mineral and protein-enriched infant formula. Pediatric Research. 295A-295A. 2000
- Influence of factor VIIa concentrates on thrombin generation in full term and preterm neonates. Thrombosis and Haemostasis. 759-760. 1999
- Randomized Trial of Feeding Nutrient-Enriched vs Standard Formula to Premature Infants during the First Year of Life. Pediatric Research. 276A-276A. 1999
- Variability in feeding practices of preterm infants <= 1.5kg. Gastroenterology. A572-A572. 1999
- Variation in Feeding Practices for Premature Infants < 1500 Grams: Impetus for Clinical Practice Guidelines. Pediatric Research. 289A-289A. 1999
- Adequate zinc status to six months corrected age in premature infants fed mothers milk pre- and post-hospital discharge. TRACE ELEMENTS IN MAN AND ANIMALS - 9. 279-281. 1997
- High iron formulas may compromise zinc but not copper status in term infants in early life. TRACE ELEMENTS IN MAN AND ANIMALS - 9. 33-34. 1997
- Zinc needs of premature infants to one year of age. TRACE ELEMENTS IN MAN AND ANIMALS - 9. 501-505. 1997
- Premature infants (PI) fed breast milk or formula have similar growth but different body composition in the first year.. Pediatric Research. 1917-1917. 1996
- Plasma ferritin (Ft) transferrin receptors (TfR) and log TfR/Ft ratio as indices of iron deficiency in infants randomized to formulas with 1.5,3,7 or 12 mg iron/L. The FASEB Journal. 1675-1675. 1996
- ADEQUATE GROWTH, BONE MINERALIZATION AND BODY-COMPOSITION IN PREMATURE-INFANTS FED A NEW MOTHERS MILK FORTIFIER WITH MODERATE PROTEIN-CONTENT AND ADDITIONAL TRACE-ELEMENTS. American Journal of Clinical Nutrition. 910-910. 1995
- ANISOYLATED STREPTOKINASE-PLASMINOGEN ACTIVATOR COMPLEX OFFERS NO ADVANTAGE OVER STREPTOKINASE FOR FIBRIN CLOT LYSIS IN CORD PLASMA. Pediatric Research. A283-A283. 1995
- ASSESSMENT OF PRETERM INFANT GROWTH AFTER TERM CORRECTED AGE - SHOULD REFERENCE-STANDARDS BE BASED ON GROWTH OF TERM OR PREMATURE-INFANTS. Pediatric Research. A301-A301. 1995
- BODY-COMPOSITION ANALYSIS BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA) OF TERM INFANTS FROM BIRTH TO 12 MONTHS. American Journal of Clinical Nutrition. 900-900. 1995
- DEXAMETHASONE-TREATED PREMATURELY BORN INFANTS WITH CHRONIC LUNG-DISEASE HAVE REDUCED GROWTH AND BONE-MINERAL ACCRETION. Pediatric Research. A322-A322. 1995
- DOES VITAMIN-C CAUSE HEMOLYSIS IN PREMATURE NEWBORNS. Pediatric Research. A203-A203. 1995
- LOW IRON FORMULAS MAINTAIN HEMATOLOGICAL STATUS IN TERM INFANTS TO ONE-YEAR OF AGE - A RCT. Pediatric Research. A301-A301. 1995
- CALCIUM GLYCEROPHOSPHATE AS CA/P SOURCE IN A NEW POWDERED FORTIFIER FOR PRETERM MOTHERS MILK - MEASUREMENT OF MINERAL BALANCES, BONE MINERALIZATION AND GROWTH. Pediatric Research. A322-A322. 1994
- DELIVERY OF EXOGENOUS SURFACTANT (SF) TO SURFACTANT-DEPLETED RABBITS BY ULTRASONIC (U) AND JET (J) NEBULIZERS (N). Pediatric Research. A332-A332. 1994
- DELIVERY OF SALBUTAMOL (S) TO INFANTS WITH BRONCHOPULMONARY DYSPLASIA (BPD) BY METERED-DOSE INHALER (MDI) AND JET NEBULIZER (JET). Pediatric Research. A332-A332. 1994
- PATTERN OF GROWTH AND BODY-COMPOSITION IN PREMATURE COMPARED TO TERM INFANTS FROM TERM TO 6 MONTHS. The FASEB Journal. A278-A278. 1994
- DOES VITAMIN-C CAUSE HEMOLYSIS IN PREMATURE NEWBORNS - RESULTS OF A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL. Blood. A96-A96. 1993
- HEREDITARY TYPE-II ALPHA(2)MACROGLOBULIN (ALPHA(2)M) DEFICIENCY. Thrombosis and Haemostasis. 685-685. 1993
- THE PERINATAL CIRCULATING ANTICOAGULANT IN MOTHER AND FETUS IS A SMALL DERMATAN SULFATE PROTEOGLYCAN. Thrombosis and Haemostasis. 720-720. 1991
- PLASMA AMINO-ACID (PAA) RESPONSES TO A TRYPTOPHAN FORTIFIED ALTERED PROTEIN FORMULA IN A RANDOMIZED TRIAL IN TERM INFANTS. Pediatric Research. A295-A295. 1991
- A CIRCULATING ANTICOAGULANT IN THE FETUS AND MOTHER. Pediatric Research. A262-A262. 1990
- THROMBIN INHIBITION IS IMPAIRED IN THE SICK NEWBORN. Pediatric Research. A273-A273. 1989
- THROMBIN GENERATION IN NEWBORN PLASMA IS DEPENDENT ON PROTHROMBIN CONCENTRATION. Arteriosclerosis. A664-A664. 1988
- THE POSTNATAL-DEVELOPMENT OF THE COAGULATION SYSTEM IN THE PREMATURE-INFANT. Thrombosis and Haemostasis. 217-217. 1987
- RED-CELL CREATINE AND FREE ERYTHROCYTE PROTOPORPHYRIN IN PREMATURE AND FULL-TERM INFANTS DURING THE 1ST 6 MONTHS OF LIFE. Pediatric Research. A392-A392. 1986
- THE POSTNATAL-DEVELOPMENT OF THE COAGULATION SYSTEM IN THE PREMATURE-INFANT. Pediatric Research. A387-A387. 1986
- POSTNATAL-DEVELOPMENT OF THE COAGULATION SYSTEM IN THE FULL-TERM INFANT. Thrombosis and Haemostasis. 259-259. 1985
- 1459 RANDOMIZED CONTROLLED TRIAL OF VIT. E. AND BRONCHOPULMONARY DYSPLASIA (BPD). Pediatric Research. 686-686. 1981
-
journal articles
- A comparison of the effect of procedural pain on cerebral oxygen saturation between late preterm and term infants. Journal of Perinatology. 44:1682-1688. 2024
- A prospective evaluation of tibial insertion sites for intraosseous needles to gain vascular access in Asian neonates. Journal of Perinatology. 2024
- Corrigendum: Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, Canada. Frontiers in Public Health. 12:1354693. 2024
- Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants. Frontiers in Pediatrics. 12:1343960. 2024
- Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants. Journal of Medical Economics. 26:630-643. 2023
- Effects of antenatal dexamethasone on postnatal serum cortisol levels in late preterm infants. Journal of Maternal-Fetal and Neonatal Medicine. 36:2224491. 2023
- Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants. Journal of Infectious Diseases. 227:1333-1334. 2023
- Prioritising respiratory syncytial virus prevention in low-income and middle-income countries. The Lancet Global Health. 11:e655-e657. 2023
- A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29–35 weeks’ gestational age. PLoS ONE. 18:e0289828-e0289828. 2023
- Comparison of the SenSmart™ and the INVOS™ neonatal cerebral near-infrared spectrometry devices. Frontiers in Pediatrics. 11:1243977. 2023
- Impact of level of neonatal care on phlebotomy and blood transfusion in extremely low birthweight infants: a prospective, multicenter, observational study. Frontiers in Pediatrics. 11:1238402. 2023
- Perspective: the potential of wastewater-based surveillance as an economically feasible game changer in reducing the global burden of pediatric respiratory syncytial virus infection. Frontiers in Public Health. 11:1316531. 2023
- Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, Canada. Frontiers in Public Health. 11:1261165. 2023
- Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada. American Journal of Perinatology. 39:1668-1677. 2022
- Perinatal Events and Outcomes Associated with Hypoxic-Ischemic Encephalopathy in Thailand: A Multicenter, Observational Study. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 105:826-832. 2022
- Respiratory syncytial virus nosocomial outbreak in neonatal intensive care: A review of the incidence, management, and outcomes. American Journal of Infection Control. 50:801-808. 2022
- Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit. Pediatric Blood and Cancer. 69:e29668. 2022
- Use of thrombolytic agents to treat neonatal thrombosis in clinical practice. Blood Coagulation and Fibrinolysis. 33:193-200. 2022
- Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study. Blood Coagulation and Fibrinolysis. 33:83-89. 2022
- Indications and outcomes of neonatal intubation: A single-center, prospective study in a middle-income country. Pediatrics and Neonatology. 63:125-130. 2022
- Are multiple births at greater risk for RSV-related hospitalisation compared with singletons?. Archives of Disease in Childhood. 107:193.1-197. 2022
- Assessment of Nurses’ Knowledge and Confidence Regarding Tracheostomy Care in a Pediatric Long Term Care Hospital in Saudi Arabia. Risk Management and Healthcare Policy. Volume 15:1809-1821. 2022
- Comparison of the Canadian vs. the international risk scoring tool for respiratory syncytial virus prophylaxis in moderate-to-late preterm infants. Frontiers in Pediatrics. 10:997349. 2022
- Impact of meconium consistency on infant resuscitation and respiratory outcomes: a retrospective-cohort study and systematic review. Journal of Maternal-Fetal and Neonatal Medicine. 34:4141-4147. 2021
- How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice. Blood Coagulation and Fibrinolysis. 32:531-538. 2021
- A Comparison of Respiratory Syncytial Viral Prophylaxis in Multiple Births versus Singletons in the Canadian Registry of Palivizumab. American Journal of Perinatology. 38:e129-e136. 2021
- Adoption in Canada of an international risk scoring tool to predict respiratory syncytial virus hospitalization in moderate-to-late preterm infants. Current Medical Research and Opinion. 37:1149-1153. 2021
- Topical nitroglycerin in newborns with ischemic injuries: A systematic review. Saudi Pharmaceutical Journal. 29:764-774. 2021
- COVID-19 Infection in Spinal Muscular Atrophy Associated with Multisystem Inflammatory Syndrome. Case Reports in Pediatrics. 2021:1-6. 2021
- What risk factors for sudden infant death syndrome are preterm and term medically complex infants exposed to at home?. Paediatrics and Child Health. 26:e184-e188. 2021
- Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries. Expert Review of Anti-Infective Therapy. 19:419-441. 2021
- A Survey of Parental Knowledge of Respiratory Syncytial Virus and Other Respiratory Infections in Preterm Infants. Neonatal Network. 40:14-24. 2021
- Exploring respiratory syncytial virus prophylaxis for children with all grades of bronchopulmonary dysplasia. Acta Paediatrica, International Journal of Paediatrics. 110:25-27. 2021
- Setting realistic goals for feeding infants when their mothers have suspected or confirmed COVID‐19. Acta Paediatrica, International Journal of Paediatrics. 109:1934-1936. 2020
- Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children. Pediatric Infectious Disease Journal. 39:539-545. 2020
- Inferior vena cava syndrome in neonates: An evidence‐based systematic review of the literature. Pediatric Blood and Cancer. 67:e28114. 2020
- Predictive factors for intensive birth resuscitation in a developing-country: a 5-year, single-center study. Journal of Maternal-Fetal and Neonatal Medicine. 33:570-576. 2020
- Expert consensus on palivizumab use for respiratory syncytial virus in developed countries. Paediatric Respiratory Reviews. 33:35-44. 2020
- Burden of respiratory syncytial virus hospitalisation among infants born at 32–35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies. Epidemiology and Infection. 148:e170. 2020
- Accuracy of Using a Point-of-Care Glucometer for Cerebrospinal Fluid Glucose Screening in Resource-Limited Countries. Hospital Pediatrics. 9:665-672. 2019
- Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017. Clinical Infectious Diseases. 69:980-986. 2019
- Palivizumab for children with Down syndrome: is the time right for a universal recommendation?. Archives of Disease in Childhood. 104:719-721. 2019
- Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab. Pediatric Infectious Disease Journal. 38:775-780. 2019
- Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab. European Journal of Clinical Microbiology and Infectious Diseases. 38:1561-1568. 2019
- Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?. Expert Review of Anti-Infective Therapy. 17:211-222. 2019
- Outcomes following neonatal portal vein thrombosis: A descriptive, single‐center study and review of anticoagulant therapy. Pediatric Blood and Cancer. 66:e27572. 2019
- Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders. European Journal of Pediatrics. 178:377-385. 2019
- Respiratory syncytial virus (RSV) infection in children with medical complexity. European Journal of Clinical Microbiology and Infectious Diseases. 38:171-176. 2019
- Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis. Journal of Pediatrics. 203:92-100.e3. 2018
- Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis. Paediatrics and Child Health. 23:441-446. 2018
- Positive end-expiratory pressure during resuscitation at birth in very-low birth weight infants: A randomized-controlled pilot trial. Pediatrics and Neonatology. 59:448-454. 2018
- Positive end-expiratory pressure during resuscitation at birth in very-low birth weight infants: A randomized-controlled pilot trial. Pediatrics and Neonatology. 59:448-454. 2018
- Pediatric superior vena cava syndrome: An evidence‐based systematic review of the literature. Pediatric Blood and Cancer. 65:e27225. 2018
- Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005–2016). European Journal of Clinical Microbiology and Infectious Diseases. 37:1345-1352. 2018
- Conservative management of neonatal cerebral sinovenous thrombosis with coexisting thrombophilia. Blood Coagulation and Fibrinolysis. 29:399-403. 2018
- Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?. European Journal of Clinical Microbiology and Infectious Diseases. 37:1113-1118. 2018
- Respiratory Syncytial Virus in Otherwise Healthy Prematurely Born Infants: A Forgotten Majority. American Journal of Perinatology. 35:541-544. 2018
- Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants. Pediatric pulmonology. Supplement. 53:605-612. 2018
- Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children. Infectious Diseases and Therapy. 7:87-120. 2018
- Adherence and outcomes: a systematic review of palivizumab utilization. Expert Review of Respiratory Medicine. 12:27-42. 2018
- Re: “Completed Weeks of Gestation and Risk of Respiratory Syncytial Virus in Late Preterm Infants”. Pediatric Infectious Disease Journal. 36:1227-1228. 2017
- Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. The Lancet Global Health. 5:e984-e991. 2017
- Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases. Infectious Diseases and Therapy. 6:383-411. 2017
- The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood. Infectious Diseases and Therapy. 6:173-197. 2017
- Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005–2015). Pediatric Infectious Disease Journal. 36:445-450. 2017
- Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease. Infectious Diseases and Therapy. 6:37-56. 2017
- First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015). European Journal of Pediatrics. 176:413-422. 2017
- Myocardial Infarction in Neonates: A Review of an Entity with Significant Morbidity and Mortality. Pediatric Cardiology. 38:427-441. 2017
- Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons. Pediatric Infectious Disease Journal. 36:160-167. 2017
- Impact of a dedicated neonatal stabilization room and process changes on stabilization time. Journal of Perinatology. 37:162-167. 2017
- The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis. Journal of Maternal-Fetal and Neonatal Medicine. 30:127-133. 2017
- Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy. Pediatric Infectious Disease Journal. 36:2-8. 2017
- Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease. Infectious Diseases and Therapy. 5:453-471. 2016
- Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease. Infectious Diseases and Therapy. 5:417-452. 2016
- Accuracy of transcutaneous bilirubin measured by the BiliCare device in late preterm and term neonates. Journal of Maternal-Fetal and Neonatal Medicine. 29:3641-3645. 2016
- Palivizumab Adherence and Outcomes in Canadian Aboriginal Children. Pediatric Infectious Disease Journal. 35:1187-1193. 2016
- Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort study. CMAJ open. 4:E615-E622. 2016
- Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infectious Diseases and Therapy. 5:271-298. 2016
- How to use unfractionated heparin to treat neonatal thrombosis in clinical practice. Blood Coagulation and Fibrinolysis. 27:605-614. 2016
- Neonatal central venous catheter thrombosis: diagnosis, management, and outcome.. Blood Coagulation and Fibrinolysis. 2016
- Patent foramen ovale and stroke in childhood: A systematic review of the literature. European Journal of Paediatric Neurology. 20:500-511. 2016
- A prospective study of the severity of early respiratory distress in late preterms compared to term infants. Journal of Maternal-Fetal and Neonatal Medicine. 29:207-212. 2016
- Respiratory Syncytial Virus Preterm (32–36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland. Pediatric Infectious Disease Journal. 35:19-24. 2016
- Assessment of the severity of visible blood in the stool using a cluster of neonatal cases –a quality improvement study. Journal of Neonatal-Perinatal Medicine. 8:379-391. 2015
- A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants. BMC Pediatrics. 15:47. 2015
- Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab. Pediatric Infectious Disease Journal. 34:e290-e297. 2015
- Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention. Expert Review of Respiratory Medicine. 9:779-799. 2015
- Letters to the Editor. Paediatrics and Child Health. 20:463-464. 2015
- Re: Joan L Robinson, Nicole Le Saux; Canadian Paediatric Society Infectious Diseases and Immunization Committee. Preventing hospitalizations for respiratory syncytial virus infection. Paediatr Child Health 2015; 20(6): 321-333. Paediatrics and Child Health. 20:463-464. 2015
- To the Editor. Paediatrics and Child Health. 20:463-464. 2015
- Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates. Journal of Perinatology. 35:852-854. 2015
- Macrolides do not affect the incidence of moderate and severe bronchopulmonary dysplasia in symptomatic ureaplasma‐positive infants. Acta Paediatrica, International Journal of Paediatrics. 104:e427-e432. 2015
- Value of a risk scoring tool to predict respiratory syncytial virus disease severity and need for hospitalization in term infants. Journal of Medical Virology. 87:1285-1291. 2015
- Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention. PLoS ONE. 10:e0134711-e0134711. 2015
- Respiratory Syncytial Virus Prophylaxis in Down Syndrome: A Prospective Cohort Study. Pediatrics. 133:1031-1037. 2014
- Respiratory syncytial virus prophylaxis in children with cardiac disease: a retrospective single-centre study. Cardiology in the Young. 24:337-343. 2014
- Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin. Transfusion. 54:640-645. 2014
- Neonatal central venous catheter thrombosis. Blood Coagulation and Fibrinolysis. 25:97-106. 2014
- Hospitalization for Respiratory Syncytial Virus Illness in Down Syndrome Following Prophylaxis With Palivizumab. Pediatric Infectious Disease Journal. 33:e29-e33. 2014
- The Real‐Life Effectiveness of Palivizumab for Reducing Hospital Admissions for Respiratory Syncytial Virus in Infants Residing in Nunavut. Canadian Respiratory Journal. 21:185-189. 2014
- Probiotics for infantile colic: a systematic review. BMC Pediatrics. 13:186. 2013
- Seasonal Respiratory Syncytial Virus Prophylaxis Based on Predetermined Dates Versus Regional Surveillance Data. Pediatric Infectious Disease Journal. 32:e436-e436. 2013
- Spontaneous neonatal arterial thromboembolism. Blood Coagulation and Fibrinolysis. 24:787-797. 2013
- Accuracy of the StatStrip versus SureStep Flexx glucose meter in neonates at risk of hypoglycemia. European Journal of Pediatrics. 172:1181-1186. 2013
- Evaluation of the Use of Low-Molecular-Weight Heparin in Neonates. Clinical and Applied Thrombosis/Hemostasis. 19:488-493. 2013
- Seasonal Respiratory Syncytial Virus Prophylaxis Based on Predetermined Dates Versus Regional Surveillance Data. Pediatric Infectious Disease Journal. 32:e360-e364. 2013
- Accuracy and precision of transcutaneous bilirubinometry in postdischarge Asian neonates. European Journal of Pediatrics. 172:781-786. 2013
- Monosomy 3pter-p25.3 and Trisomy 1q42.13-qter in a Boy With Profound Growth and Developmental Restriction, Multiple Congenital Anomalies, and Early Death. Pediatrics and Neonatology. 54:202-206. 2013
- The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence. Journal of Medical Economics. 16:115-124. 2013
- Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey.. Turkish Journal of Pediatrics. 55:564-567. 2013
- Diagnosis and treatment of intracranial hemorrhage in children with hemophilia. Blood Coagulation and Fibrinolysis. 24:23-27. 2013
- Diagnosis and treatment of intracranial hemorrhage in children with hemophilia. Blood Coagulation and Fibrinolysis. 24:23-27. 2013
- Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union. Journal of Immunology Research. 2013:1-6. 2013
- Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries. Journal of Immunology Research. 2013:1-15. 2013
- Topical Nitroglycerine for Neonatal Arterial Associated Peripheral Ischemia following Cannulation: A Case Report and Comprehensive Literature Review. Case Reports in Pediatrics. 2013:1-7. 2013
- Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory‐syncytial‐virus‐related infection in cystic fibrosis children less than 2 years of age?. Journal of Paediatrics and Child Health. 48:1033-1038. 2012
- A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS). European Journal of Clinical Microbiology and Infectious Diseases. 31:2703-2711. 2012
- A review of cost–effectiveness of palivizumab for respiratory syncytial virus. Expert Review of Pharmacoeconomics and Outcomes Research. 12:553-567. 2012
- Corrigendum to: “High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention” [Early Human Development 88S2 (2012) S34–S41]. Early Human Development. 88:845-845. 2012
- Neonatal and infant pulmonary thromboembolism. Blood Coagulation and Fibrinolysis. 23:653-662. 2012
- Erratum to: Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations. European Journal of Pediatrics. 171:1419-1419. 2012
- Perceived barriers to the implementation of a baby friendly initiative in Jeddah, Saudi Arabia.. Saudi Medical Journal. 33:895-900. 2012
- High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention. Early Human Development. 88:S34-S41. 2012
- Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations. European Journal of Pediatrics. 171:833-841. 2012
- Fetal Intracerebral Mass With Major Perinatal Implications. NeoReviews. 13:e251-e253. 2012
- CARESS. Pediatric Infectious Disease Journal. 31:213-213. 2012
- CARESS. Pediatric Infectious Disease Journal. 31:212-213. 2012
- Identifying and Ensuring Optimal Care for All Children at Risk of Developing Serious Respiratory Syncytial Virus Disease: A Canadian Nurses’ Perspective. Neonatal Network. 31:369-386. 2012
- Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010. Emerging Infectious Diseases. 18:120-124. 2012
- Practical Resources for Nurses and Other Health Care Providers Involved in the Care of Children at Risk for Respiratory Syncytial Virus Infection. Neonatal Network. 31:387-400. 2012
- Premedication for neonatal intubation: Current practice in Saudi Arabia. Saudi Journal of Anaesthesia. 6:385-385. 2012
- Strategies for Reducing the Risk of Respiratory Syncytial Virus Infection in Infants and Young Children: A Canadian Nurses’ Perspective. Neonatal Network. 31:357-368. 2012
- Superior mesenteric artery syndrome: a rare cause of complete intestinal obstruction in neonates. Journal of Pediatric Surgery. 46:e29-e31. 2011
- Success rate and neonatal morbidities associated with early extubation in extremely low birth weight infants. Annals of Saudi Medicine. 31:577-580. 2011
- CARESS: The Canadian Registry of Palivizumab. Pediatric Infectious Disease Journal. 30:651-655. 2011
- Index of Suspicion in the NurseryCase 1: Hypoglycemia and High Hematocrit in a Term TwinCase 2: Lethargy in Twins: Double TroubleCase 3: Skin Rash, Poor Feeding, and Diarrhea in a 22-day-old Male. NeoReviews. 12:e463-e471. 2011
- The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study. European Journal of Pediatrics. 170:907-913. 2011
- Acute life threatening events associated with hypocalcemia and vitamin D deficiency in early infancy. A single center experience from the Kingdom of Saudi Arabia.. Saudi Medical Journal. 32:528-530. 2011
- Are late preterm infants as susceptible to RSV infection as full term infants?. Early Human Development. 87:S47-S49. 2011
- Special populations: Do we need evidence from randomized controlled trials to support the need for respiratory syncytial virus prophylaxis?. Early Human Development. 87:S55-S58. 2011
- Fetal and Neonatal Alloimmune Thrombocytopenia: Harvesting the Evidence to Develop a Clinical Approach to Management. American Journal of Perinatology. 28:137-144. 2011
- A Decade of Respiratory Syncytial Virus Epidemiology and Prophylaxis: Translating Evidence into Everyday Clinical Practice. Canadian Respiratory Journal. 18:e10-e19. 2011
- Changing costs and the impact on RSV prophylaxis. Journal of Medical Economics. 13:705-708. 2010
- Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection.. Canadian Family Physician. 56:988-991. 2010
- Neonatal Cerebral Sinovenous Thrombosis: Sifting the Evidence for a Diagnostic Plan and Treatment Strategy. Pediatrics. 126:e693-e700. 2010
- Patent Ductus Arteriosus: Optimal Fluid Requirements in Preterm Infants. NeoReviews. 11:e495-e502. 2010
- The cost effectiveness of palivizumab: a systematic review of the evidence. Journal of Medical Economics. 13:453-463. 2010
- Neonatal Aortic Thrombosis: A Comprehensive Review. Klinische Padiatrie. 222:134-139. 2010
- Remifentanil for endotracheal intubation in neonates: a randomised controlled trial. Archives of Disease in Childhood: Fetal and Neonatal Edition. 95:F80-F84. 2010
- The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic. Journal of Medical Economics. 12:361-370. 2009
- Outcomes of Late-Preterm Infants: A Retrospective, Single-Center, Canadian Study. Clinical Pediatrics. 48:844-850. 2009
- Comparison of the Cost of Hospitalization for Respiratory Syncytial Virus Disease Versus Palivizumab Prophylaxis in Canadian Inuit Infants. Pediatric Infectious Disease Journal. 28:702-706. 2009
- Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis. Current Medical Research and Opinion. 25:1631-1633. 2009
- Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis Reply. Current Medical Research and Opinion. 25:1632-1633. 2009
- Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33–35 completed weeks’ gestational age in Canada. Current Medical Research and Opinion. 25:1585-1591. 2009
- Outcomes of Late-Preterm Infants at Mcmaster Children's Hospital (Mch): a Retrospective, Single-Center Comparative Study. Paediatrics and Child Health. 14:50A-50A. 2009
- Clinical implication of the difference between transcutaneous bilirubinometry and total serum bilirubin for the classification of newborns at risk of hyperbilirubinemia. Clinical Biochemistry. 42:176-179. 2009
- Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practice. Annals of Pediatric Cardiology. 2:120-120. 2009
- The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis. Current Medical Research and Opinion. 24:3223-3237. 2008
- Quality improvement in radiography in a neonatal intensive care unit.. Canadian Association of Radiologists Journal. 59:197-202. 2008
- Development and Validation of a Risk Scoring Tool to Predict Respiratory Syncytial Virus Hospitalization in Premature Infants Born at 33 through 35 Completed Weeks of Gestation. Medical decision making. 28:471-480. 2008
- A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia. Transfusion. 48:92-98. 2008
- A Case Report of a Premature Infant With Coxsackie B1 Meningitis. Advances in Neonatal Care. 7:238-247. 2007
- Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood. 107:3761-3763. 2006
- Neonatal Hepatoblastoma: Two Cases Posing a Diagnostic Dilemma, with a Review of the Literature. American Journal of Perinatology. 22:413-419. 2005
- Streptococcus pneumoniae: An Old Bug with Significant Maternal-Newborn Implications. American Journal of Perinatology. 21:491-495. 2004
- Carnitine supplementation for preterm infants with recurrent apnoea. Cochrane Database of Systematic Reviews. 2011:CD004497. 2004
- The Pediatric Investigators Collaborative Network on Infections in Canada Study of Predictors of Hospitalization for Respiratory Syncytial Virus Infection for Infants Born at 33 Through 35 Completed Weeks of Gestation. Pediatric Infectious Disease Journal. 23:806-814. 2004
- Role of Carnitine Supplementation in Apnea of Prematurity: A Systematic Review. Journal of Perinatology. 24:158-163. 2004
- Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin. Thrombosis and Haemostasis. 91:1009-1018. 2004
- Contralateral Cerebral Infarction Following Vacuum Extraction. Journal of Perinatology. 21:15-17. 2004
- Epidural Opioid Analgesia and Neonatal Respiratory Depression. Journal of Perinatology. 23:425-427. 2003
- Closed Suctioning of Intubated Neonates Maintains Better Physiologic Stability: A Randomized Trial. Journal of Perinatology. 23:218-222. 2003
- Current strategies in the prevention of respiratory syncytial virus disease. Paediatric Respiratory Reviews. 4:21-27. 2003
- Case report and review of the perinatal implications of maternal lithium use. American Journal of Obstetrics and Gynecology. 187:245-249. 2002
- Late-onset left diaphragmatic hernia after group B streptococcal sepsis: An unusual presentation. Journal of Pediatric Surgery. 37:932-933. 2002
- Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes. Pediatric Infectious Disease Journal. 21:512-518. 2002
- Comparison of Capillary Blood Sampling Using an Automated Incision Device With and Without Warming the Heel. Journal of Perinatology. 22:154-158. 2002
- A MATCHED COHORT STUDY OF FEEDING PRACTICE GUIDELINES FOR INFANTS WEIGHING LESS THAN 1,500 G. Advances in Neonatal Care. 2:27-36. 2002
- EVIDENCE-BASED FEEDING GUIDELINES FOR VERY LOW-BIRTH-WEIGHT INFANTS. Advances in Neonatal Care. 2:5-18. 2002
- Orbital lymphangioma with non‐contiguous cerebral arteriovenous malformation, manifesting with thrombocytopenia (Kasabach‐Merritt syndrome) and intracerebral hemorrhage. Acta Paediatrica, International Journal of Paediatrics. 91:98-99. 2002
- Posterior fossa haemorrhage in a preterm infant following vacuum assisted delivery. British Journal of Obstetrics and Gynaecology. 108:1008-1010. 2001
- Posterior fossa haemorrhage in a preterm infant following vacuum assisted delivery. BJOG: An International Journal of Obstetrics and Gynaecology. 108:1008-1010. 2001
- Ovarian Cyst in a Premature Infant Treated with Spironolactone. American Journal of Perinatology. 18:353-356. 2001
- Spontaneous Rupture of the Liver Presenting as Scrotal Bruising. American Journal of Perinatology. 18:147-150. 2001
- Wolf-Hirschorn syndrome resulting from partial monosomy 4p/trisomy 9p. American Journal of Medical Genetics, Part A. 93:285-289. 2000
- A randomized trial comparing peripherally inserted central venous catheters and peripheral intravenous catheters in infants with very low birth weight. Journal of Pediatric Surgery. 35:1040-1044. 2000
- Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns. Blood Coagulation and Fibrinolysis. 11:349-357. 2000
- Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates. Blood Coagulation and Fibrinolysis. 11:S133-S134. 2000
- Gastrointestinal Function and Growth in Premature Infants: Is Non-Nutritive Sucking Vital?. Journal of Perinatology. 20:46-53. 2000
- CONGENITAL VARICELLA SYNDROME:A RARE CASE OF CENTRAL NERVOUS SYSTEM INVOLVEMENT WITHOUT DERMATOLOGICAL FEATURES. American Journal of Perinatology. Volume 17:253-256. 2000
- RECURRENT FAMILIAL NEONATAL DEATHS: HEREDITARY SURFACTANT PROTEIN B DEFICIENCY. American Journal of Perinatology. Volume 17:219-224. 2000
- Bone metabolism and circulating IGF-I and IGFBPs in dexamethasone-treated preterm infants. Early Human Development. 56:127-141. 1999
- Cisapride: The Problem of the Heart. Neonatal Network. 18:21-25. 1999
- De novo deletion 12q: Report of a patient with 12q24.31q24.33 deletion. American Journal of Medical Genetics, Part A. 84:116-119. 1999
- Growth and body composition of preterm infants: influence of nutrient fortification of mother's milk in hospital and breastfeeding post‐hospital discharge. Acta Paediatrica, International Journal of Paediatrics. 87:780-785. 1998
- Moderate nutrient supplementation of mother’s milk for preterm infants supports adequate bone mass and short-term growth: a randomized, controlled trial. American Journal of Clinical Nutrition. 67:465-472. 1998
- Sucrose and commercially available milk reduced crying in newborns during a blood collection procedure. Evidence-Based Nursing. 1:10-10. 1998
- Cisapride: a review of the evidence supporting its use in premature infants with feeding intolerance.. Neonatal Network. 16:17-21. 1997
- Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Human Development. 47:271-286. 1997
- Does vitamin C cause hemolysis in premature newborn infants? Results of a multicenter double-blind, randomized, controlled trial. Journal of Pediatrics. 130:103-109. 1997
- A Controlled Trial of Nurse Practitioners in Neonatal Intensive Care. Pediatrics. 98:1143-1148. 1996
- A controlled trial of nurse practitioners in neonatal intensive care. Pediatrics. 98:1143-1148. 1996
- Decreased Thrombin Activity of Fibrin Clots Prepared in Cord Plasma Compared with Adult Plasma. Pediatric Research. 39:826-830. 1996
- Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatric pulmonology. Supplement. 21:301-309. 1996
- A new measure of parent satisfaction with medical care provided in the neonatal intensive care unit. Journal of Clinical Epidemiology. 49:313-318. 1996
- Evaluation of an Educational Program to Prepare Neonatal Nurse Practitioners. Journal of Nursing Education. 34:286-289. 1995
- GROUP-B STREPTOCOCCUS - RESPONSE. Canadian Family Physician. 41:783-784. 1995
- α2-Macroglobulin Remains as Important as Antithrombin III for Thrombin Regulation in Cord Plasma in the Presence of Endothelial Cell Surfaces. Pediatric Research. 37:373-378. 1995
- Discordant fibular aplasia in twins. American Journal of Medical Genetics, Part A. 55:225-228. 1995
- Changing Physicians' Behavior Using Combined Strategies and an Evidence-Based Protocol. JAMA Pediatrics. 148:1277-1277. 1994
- Fanconi anemia in a child previously diagnosed as Baller‐Gerold syndrome. American Journal of Medical Genetics, Part A. 50:98-99. 1994
- Congenital hypothyroidism: diagnosis and management.. Neonatal Network. 12:25-34. 1993
- Appraisal of Meconium at Delivery. Obstetrical and Gynecological Survey. 48:457-458. 1993
- A Comparative Study of Heel-stick Devices for Infant Blood Collection. JAMA Pediatrics. 147:346-346. 1993
- Protein metabolism and growth of term infants in response to a reduced-protein, 40:60 whey: casein formula with added tryptophan. American Journal of Clinical Nutrition. 56:1004-1011. 1992
- Aplasia cutis congenita: a clinical review and associated defects.. Neonatal Network. 11:17-27. 1992
- Cloacal exstrophy: Prenatal diagnosis before rupture of the cloacal membrane. Journal of Pediatric Surgery. 27:1352-1355. 1992
- Pulmonary interstitial emphysema: a review.. Neonatal Network. 11:7-31. 1992
- SUCTIONING NEWBORNS. Canadian Family Physician. 38:1813-1820. 1992
- Suctioning Newborns: A practical guide to when and how.. Canadian Family Physician. 38:1813-1820. 1992
- Value of Superficial Cultures: Diagnosing neonatal sepsis in a community hospital.. Canadian Family Physician. 38:1796-1800. 1992
- Thrombin Inhibition Is Impaired in Plasma of Sick Neonates. Pediatric Research. 31:391-395. 1992
- An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.. Journal of Clinical Investigation. 89:321-326. 1992
- Definition of an Advanced Nursing Practice Role in the NICU. Clinical Nurse Specialist. 6:91-96. 1992
- Fibrin Clot Lysis by Thrombolytic Agents Is Impaired in Newborns due to a Low Plasminogen Concentration. Thrombosis and Haemostasis. 68:325-330. 1992
- Management of Prenatally Diagnosed Tracheal Obstruction: Access to the Airway in Utero Prior to Delivery. Fetal Diagnosis and Therapy. 7:12-16. 1992
- Evaluation of Graduating Neonatal Nurse Practitioners. Pediatrics. 88:789-794. 1991
- Subcutaneous fat necrosis of the newborn with hypercalcemia: a review.. Neonatal Network. 10:7-14. 1991
- Baller‐Gerold syndrome associated with congenital hydrocephalus. American Journal of Medical Genetics, Part A. 40:307-310. 1991
- Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight. European Respiratory Journal. 4:188-190. 1991
- Hypernatremia associated with N-acetylcysteine therapy for meconium ileus in a premature infant (Reply). CANADIAN MEDICAL ASSOCIATION JOURNAL. 143:999. 1990
- Evaluation of an automated bleeding time device in the newborn. American Journal of Hematology. 35:275-277. 1990
- Hypernatremia associated with N-acetylcysteine therapy for meconium ileus in a premature infant.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 143:202-203. 1990
- Neonatal Cardio-pulmonary Arrest: Emergency Catheterization of Umbilical Vein.. Canadian Family Physician. 36:1135-1140. 1990
- Peritoneal dialysis in the neonate.. Neonatal Network. 8:41-44. 1990
- Subcutaneous fat necrosis with hypercalcemia.. Canadian Association of Radiologists Journal. 41:158-159. 1990
- NEONATAL RESUSCITATION - RESPONSE. Canadian Family Physician. 36:221-221. 1990
- Development of the Hemostatic System in the Neonate and Young Infant. Journal of Pediatric Hematology/Oncology. 12:95-104. 1990
- Erratum: Intravenous infusion by superficial vein in the neonate (Journal of Intravenous Nursing, v. 13, n. 2, March/April 1990, pp. 122-128). Journal of Infusion Nursing. 13:229. 1990
- Intravenous infusion by superficial vein in the neonate.. Journal of Infusion Nursing. 13:122-128. 1990
- Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin. Thrombosis and Haemostasis. 63:027-030. 1990
- Tibial aplasia-ectrodactyly with twinning and hydrocephalus. Dysmorphology and Clinical Genetics. 3:28-32. 1989
- Neonatal resuscitation: a pictorial review.. Canadian Family Physician. 35:1477-1487. 1989
- Medical staffing in Ontario neonatal intensive care units.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 140:1321-1326. 1989
- Modified bleeding time in the infant. American Journal of Hematology. 30:190-191. 1989
- Development of the human coagulation system in the healthy premature infant. Blood. 72:1651-1657. 1988
- Fetal renal failure associated with intrauterine growth retardation. American Journal of Obstetrics and Gynecology. 159:1200-1202. 1988
- Birth asphyxia: does the Apgar score have diagnostic value?. Obstetrics and Gynecology. 72:120-123. 1988
- Pulmonary interstitial emphysema: selective bronchial occlusion with a Swan-Ganz catheter.. Archives of Disease in Childhood. 63:313-315. 1988
- Oral Sotalol in Neonatal Supraventricular Tachycardia. Acta Paediatrica, International Journal of Paediatrics. 77:171-171. 1988
- Developmental changes in red cell creatine and free erythrocyte protoporphyrin in healthy premature infants during the first six months of life. Journal of Pediatrics. 111:745-747. 1987
- Development of the human coagulation system in the full-term infant. Blood. 70:165-172. 1987
- An Audit of the Effect of Two Cord-Care Regimens on Bacterial Colonization in Newborn Infants. Joint Commission Journal on Quality and Patient Safety. 13:109-114. 1987
- Acute peritoneal dialysis in infants weighing <1500 g. Journal of Pediatrics. 110:126-129. 1987
- Oral Vitamin E Supplementation for the Prevention of Anemia in Premature Infants: A Controlled Trial. Pediatrics. 79:61-68. 1987
- Developmental changes in red cell creatine and free erythrocyte protoporphyrin in healthy full-term infants during the first 6 months of life. Journal of Pediatrics. 108:732-734. 1986
- Fatal malformations of the larynx and upper trachea. The Laryngoscope. 94:1477-1481. 1984
- Infantile centronuclear myopathy. Journal of the Neurological Sciences. 60:79-88. 1983
- Vitamin E and bronchopulmonary dysplasia. Journal of Pediatrics. 103:169-170. 1983
- Benign intracranial teratoma—Prenatal diagnosis influencing early delivery. American Journal of Obstetrics and Gynecology. 143:600-601. 1982
- Randomized controlled trial of vitamin E and bronchopulmonary dysplasia (BPD). Pediatric Research. 15. 1981